Family history and risk of stomach cancer in Warsaw, Poland

European Journal of Cancer Prevention

Volumn 8, Issue 3, 1999, Pages 223-227

  Lissowska, J ^a,d   Groves, F D ^a   Sobin, L H ^a,b   Fraumeni, J F ^a,b,c   Nasierowska Guttmejer, A ^a   Radziszewski, J ^a   Regula J ^a   Hsing, A W ^a,b   Zatonski, W ^a,b   Blot, W J ^a,b   Chow, W H ^a,b,c  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

Case control study; Family history; Poland; Stomach cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MALE; POLAND; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER;

EID: 0032739612     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199906000-00010     Document Type: Article

References (32)

1. Aird I, Bcntall HH, Roberts JAF (1953). A relationship between cancer of stomach and the ABO blood groups. BMJ 1: 799-801.
2. Airewele G, Adatto P, Cunningham J et al. (1998). Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 90: 543-4.
3. Blaser MJ, Chyou PH, Nomura A (1995). Age at establishment of Helicobacterpylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 55: 562-5.
4. Bonney GE, Elston RC, Correa P et al. (1986). Genetic etiology of gastric carcinoma. I. Chronic atrophie gastritis. Genetic Epidemiol 3: 213-24.
5. Breslow NE, Day NE (1980). Statistical methods in cancer research. Vol.1 Tlie analysis of case-control studies. I ARC Scientific Publications No 32, Lyon.
6. Chow WH, Swanson C, Lissowska J et al. (1999). Risk of stomach cancer in relation to consumption of cigarette, alcohol and beverage in Warsaw, Poland. Int J Cancer (in press).
7. Gayther SA, Gorringe KL, Ramus SJ et al. (1998). Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58: 4086-9.
8. Guilford P, Hopkins J, Harraway J et al. (1998). E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-5.
9. Hennekens CH, Buring JE (1987). Epidemiology in medicine. Little Brown and Company, Boston, pp. 90-3.
10. Ihamaki T, Varis K, Kekki M, Siurala M. (1991). Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples. Scand J Gastroenterol 26(Suppl 186): 16-23.
11. Inoue M, Tajima K, Yamamura Y et al. (1998). Family history and subsite of gastric cancer: data from a case-referent study in Japan, Int J Cancer 76: 801-5.
12. Kato I, Tominaga S, Ito Y et al. (1990). A comparative case-control analysis of stomach cancer and atrophie gastritis. Cancer Res 50: 6559-64.
13. Kikuchi S, Nakajima T, Nishi T et al. (1996). Association between family history and gastric carcinoma among young adults. Jpn J Cancer Res 87: 332-6.
14. La Vecchia C, Negri E, Franceschi S, Gentile A (1992). Family history and risk of stomach cancer and colorectal cancer. Cancer 70: 50-55.
15. Laurén P (1965). The two histological main types of gastric cancer: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 64: 31-49.
16. Laurén PA, Nevalainen TJ (1993). Epidemiology of intestinal and diffuse types of gastric carcinoma. Cancer 71: 2926-33.
17. Lethola J (1978). Family study of gastric carcinoma; with special reference to histological types. Scand J Gastroenterol 13(Suppl 50): 1-54.
18. Love RR, Evans AM, Josten DM (1985). The accuracy of patient reports of family history of cancer. J Cliron Dis 38: 289-93.
19. Mecklin JP, Nordling S, Saario I (1988). Carcinoma of stomach and its heredity in young patients. Scand J Gastroenterol 23: 307-11.
20. Meining A, Hackelsberger A, Daenecke C et al. (1998). Increased cell proliferation of the gastric mucosa in first-degree relatives of gastric carcinoma patients. Cancer 83: 876-81.
21. Nagase H, Ogino K, Yoshida I et al. (1996). Family history-related risk of gastric cancer in Japan: a hospital-based case-control study. Jpn J Cancer Res 87: 1025-9.
22. Nomura A (1996). Stomach cancer. In Cancer epidemiology and prevention (2nd edn) (eds Schottenfeld D, Fraumeni JF Jr); Oxford University Press, New York, pp. 707-24.
23. Ogawa H, Kato I, Tominaga S (1985). Family history of cancer among cancer patients. Jpn J Cancer Res 76: 113-18.
24. Ottini L, Palli D, Falchetti M et al. (1997). Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 57: 4523-9.
25. Palli D, Galli M, Caporaso NE et al. (1994). Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 3: 15-18.
26. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997). Cancer incidence in five continents, Vol VIL IARC Scientific Publications No. 143. International Agency for Research on Cancer, Lyon.
27. Parsonnet J, Vandersteen D, Goates J et al. (1991). Helicobacter pylori infection in intestinal- and diffuse type gastric adenocarcinomas. J Natl Cancer fust 83: 640-3.
28. Webb PM, Knight T, Greaves S et al. (1994). Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person-to-person transmission in early life. Dr Med J 308: 750-3.
29. Zanghieri G, Di Gregorio C, Sacchetti C et al. (1990). Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66: 2047-51.
30. Zatonski W, Smans M, Tyczynski J, Boyle P (1996). Atlas of cancer mortality in central Europe. IARC Scientific Publication No 134, IARC, Lyon.
31. Zatonski V, Tyczynski J (1999). Cancer in Poland in 1996. The Maria Sklodowska-Curie Memorial Cancer Center, Department of Epidemiology and Cancer Prevention, National Cancer Registry, Warsaw, Poland.
32. Zhao L, Blot WJ, Liu WD et al. (1994). Familial predisposition to precancerous gastric lesions in a high-risk area of China. Cancer Epidemiol Biomarkers Prev 3: 461-4.